News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Monday, September 23, 2024Pfizer Inc and BioNTech SE announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has recommended marketing authorization for the companies Omicron KPadapted monovalent COVID vaccine
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
Friday, September 20, 2024Bavarian Nordic AS announced today that the European Commission has adopted the Committee for Medicinal Products for Human Use CHMP recommendation for the approval of a type II variation for IMVANEX MVABN smallpox and mpox vaccine
Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals
Friday, September 20, 2024Axcelead Drug Discovery Partners Inc announced on September that it had entered into a Master Service Agreement with Acadia Pharmaceuticals Inc to support their goal of discovering and developing innovative and novel medicines
QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform
Thursday, September 19, 2024QIAGEN announced an important milestone with the launch of new assays for its digital PCR dPCR platform QIAcuity for use in the study of cancer inherited genetic disorders infectious disease surveillance and food and environmental monitoring
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
Thursday, September 19, 2024Certara Inc a global leader in modelinformed drug development today shared the results from its collaboration with Ichnos Glenmark Innovation IGI on the firstinhuman dose prediction and selection for ISB IGIs drug candidate is a trispecific Tcell en...
Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980
Wednesday, September 18, 2024Monument Therapeutics a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology today announced that the United Kingdom Intellectual Property Office IPO has granted UK patent GB
Thermo Fisher Scientific Announces Expansion of Bioanalytical Laboratory Services in Europe
Wednesday, September 18, 2024The PPD clinical research business of Thermo Fisher Scientific the world leader in serving science announced today the expansion of its global laboratory services with a new bioanalytical lab in GoCo Health Innovation City in Gothenburg Sweden
Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis
Monday, September 16, 2024Ipsen announced detailed final overall survival OS data from the Phase III CONTACT trial investigating the combination of Cabometyx cabozantinib and atezolizumab in metastatic castrationresistant
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B
Monday, September 16, 2024AAVantgarde Bio AAVantgarde an Italybased global biotechnology company announced that the first subject has been dosed in the LUCE trial a Phase open label clinical trial to assess safety and tolerability of AAVB
Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
Friday, September 13, 2024As part of its effort to develop innovative treatments for people living with rare cancers Sanofi has entered into an exclusive licensing agreement with RadioMedix Inc
